These data suggested that ALL and CML-BP patients possessed more heterogeneous BCR-ABL1 cloned cells, indicating greater chromosomal abnormality and genomic instability. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.